Afaghi S et al (2021) Prevalence and clinical outcomes of vitamin D deficiency in COVID-19 hospitalized patients: a retrospective single-center analysis. Tohoku J Exp Med 255(2):127–134

Article  PubMed  Google Scholar 

Alachkar H, Santhanam R, Harb JG, Lucas DM, Oaks JJ, Hickey CJ et al (2013) Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol 6:21. https://doi.org/10.1186/1756-8722-6-21

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ali HM, Ellakwa DES, Elaraby NM, Zaher AM, Amr KS (2023) Study the association of microRNA polymorphisms (miR-146a, miR-4513) with the risk of coronary heart diseases in Egyptian population. J Biochem Mol Toxicol 37(3):e23284

Article  PubMed  CAS  Google Scholar 

Alves R et al (2019) MicroRNA Signature Refine Response Prediction in CML. Sci Rep 9(1):9666

Article  PubMed  PubMed Central  Google Scholar 

Alwaeely FA, Madlum KN, Alsaadi MA (2021) Immunomodulatory effect of propolis on foxp3 gene expression in human peripheral blood mononuclear cells stimulated in vitro with pseudomonas aeruginosa Ag. Arch Razi Inst 76(4):887–894. https://doi.org/10.22092/ari.2021.355389.1678

Ambrosinom G, Ruberti S (2021) MicroRNAs as prognostic biomarkers in acute myeloid leukemia: a comprehensive review. Leuk Res 100:106489

Google Scholar 

Amodio N et al (2019) Replacement of miR-155 elicits tumor suppressive activity and antagonizes bortezomib resistance in multiple myeloma. Cancers 11(2):236

Article  PubMed  PubMed Central  CAS  Google Scholar 

Annese T, Tamma R, De Giorgis M, Ribatti D (2020) microRNAs biogenesis, functions and role in tumor angiogenesis. Front Oncol 10(November):1–21. https://doi.org/10.3389/fonc.2020.581007

Article  Google Scholar 

Bartel DP (2018) Review metazoan microRNAs. Cell 173(1):20–51. https://doi.org/10.1016/j.cell.2018.03.006

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bayraktar E, Bayraktar R, Oztatlici H, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C (2023) Targeting miRNAs and other non-coding RNAs as a therapeutic approach: an update. Non-Coding RNA 9(2):27

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bayraktar R, Van Roosbroeck K, Calin GA (2017) Cell-to-cell communication : microRNAs as hormones. 11:1673–1686https://doi.org/10.1002/1878-0261.12144

Becker H, Marcucci G, Maharry K, Radmacher MD, Mrózek K, Margeson D et al (2010) Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a cancer and leukemia group B study. J Clin Oncol 28(4):596–604. https://doi.org/10.1200/jco.2009.25.1496

Article  PubMed  CAS  Google Scholar 

Bento L et al (2022) Screening for Prognostic microRNAs Associated with Treatment Failure in Diffuse Large B Cell Lymphoma. Cancers 14(4):1065

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bhatnagar B, Garzon R (2021) Clinical applications of microRNAs in acute myeloid leukemia: a mini-review. Front Oncol 11(11):679022. https://doi.org/10.3389/fonc.2021.679022

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bollaert E et al (2021) MiR-15a-5p confers chemoresistance in acute myeloid leukemia by inhibiting autophagy induced by daunorubicin. Int J Mol Sci 22(10):5153

Article  PubMed  PubMed Central  CAS  Google Scholar 

Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857–866. https://doi.org/10.1038/nrc1997

Article  PubMed  CAS  Google Scholar 

Carvajal-Moreno J et al (2023) Effects of hsa-miR-9-3p and hsa-miR-9-5p on topoisomerase IIβ expression in human leukemia K562 cells with acquired resistance to etoposide. J Pharmacol Exp Ther 384(2):265–276

Article  PubMed  PubMed Central  CAS  Google Scholar 

Chakraborty C, Sharma AR, Sharma G, Lee SS (2021) Therapeutic advances of miRNAs: a preclinical and clinical update. J Adv Res 1(28):127–138

Article  Google Scholar 

Chen D, Wu D, Shao K, Ye B, Huang J, Gao Y (2017) MiR-15a-5p negatively regulates cell survival and metastasis by targeting CXCL10 in chronic myeloid leukemia. Am J Transl Res 9(9):4308

PubMed  PubMed Central  CAS  Google Scholar 

Chen X et al (2019) miR-1271-5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2. Mol Med Rep 19(1):508–514

PubMed  CAS  Google Scholar 

Ciftci IH, Radwan OM, Ozturk ES, Ulusoy NG, Sozer E, Ellakwa ED, Ocak Z, Can MFS, Ali TI, Abd-Alla H et al (2019) Design, synthesis and biological evaluation of pentacyclic triterpene derivatives: optimization of anti-ABL kinase activity. Molecules 24(19):3535. https://doi.org/10.3390/molecules24193535

Article  CAS  Google Scholar 

Concepcion CP, Bonetti C, Ventura A (2012) The microRNA-17-92 family of microRNA clusters in development and disease. Cancer J 18(3):262–267

Article  PubMed  PubMed Central  CAS  Google Scholar 

de Leeuw D, Denkers F, Olthof MC, Rutten AP, Pouwels W, Schuurhuis GJ et al (2014) Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res 74(7):2094–2105. https://doi.org/10.1158/0008-5472

Article  PubMed  Google Scholar 

Diener C, Keller A, Meese E (2022) Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet 38(6):613–626

Article  PubMed  CAS  Google Scholar 

Ding Q et al (2018) MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells. Biochem Cell Biol 96(6):840–846

Article  PubMed  CAS  Google Scholar 

Dorrance AM, Neviani P, Ferenchak GJ, Huang X, Nicolet D, Maharry KS et al (2015) Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia. Leukemia 29(11):2143–2153. https://doi.org/10.1038/leu.2015.139

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ellakwa DES, Mushtaq N, Khan S, Jabbar A, Abdelmalek MA, Wadan AHS, ... Raza A (2024) Molecular functions of microRNAs in colorectal cancer: recent roles in proliferation, angiogenesis, apoptosis, and chemoresistance. Naunyn-Schmiedeberg's Arch Pharmacol 1–14

Fang ZH et al (2016) miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathways. Cell Death Dis 7(9):e2371

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fang LL, Wang XH, Sun BF, Zhang XD, Zhu XH, Yu ZJ, Luo H (2017) Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells. Int J Mol Med 40(6):1624–1630

PubMed  PubMed Central  CAS  Google Scholar 

Fei J et al (2012) miR-181a post-transcriptionally downregulates oncogenic RalA and contributes to growth inhibition and apoptosis in chronic myelogenous leukemia (CML). PLoS ONE 7(3):e32834

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fonte E et al (2013) In Vitro Sensitivity of CLL Cells to Fludarabine May Be Modulated by the Stimulation of Toll-like Receptors. Clin Cancer Res 19(2):367–379

Article  PubMed  CAS  Google Scholar 

Gao Y, Lin L, Li T, Yang J, Wei Y (2017) The role of miRNA-223 in cancer: function, diagnosis and therapy. Gene 616:1–7. https://doi.org/10.1016/j.gene.2017.03.021

Article  PubMed  CAS  Google Scholar 

Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F et al (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111(6):3183–3189. https://doi.org/10.1182/blood-2007-07-098749

Article